Barclays’s Plus Therapeutics PSTV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Hold |
0
| – | – | – | 5347 |
|
|
2025
Q4 | – | Hold |
0
| – | – | – | 5192 |
|
|
2025
Q3 | – | Sell |
-4
| Closed | -$49 | – | 5451 |
|
|
2025
Q2 | $36 | Sell |
4
-38
| -90% | -$497 | ﹤0.01% | 5130 |
|
|
2025
Q1 | $987 | Buy |
+42
| New | +$1.17K | ﹤0.01% | 5051 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 4976 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 5293 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 5351 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 5060 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 5208 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 5477 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 7043 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 7196 |
|
|
2019
Q1 | – | Sell |
-5
| Closed | -$26.4K | – | 7258 |
|
|
2018
Q4 | $29K | Buy |
5
+4
| +400% | +$26.3K | ﹤0.01% | 5743 |
|
|
2018
Q3 | $5K | Buy |
+1
| New | +$12.7K | ﹤0.01% | 6794 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 7217 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 7269 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 7067 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 6765 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 6438 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 6491 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 6365 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 6152 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 5867 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 6378 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 6458 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 6998 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 7162 |
|
|
2015
Q1 | – | Hold |
0
| – | – | – | 6771 |
|
|
2014
Q4 | – | Hold |
0
| – | – | – | 7531 |
|
|
2014
Q3 | – | Hold |
0
| – | – | – | 7791 |
|
|
2014
Q2 | – | Hold |
0
| – | – | – | 7406 |
|
|
2014
Q1 | – | Hold |
0
| – | – | – | 7030 |
|
|
2013
Q4 | – | Hold |
0
| – | – | – | 6598 |
|
|
2013
Q3 | – | Hold |
0
| – | – | – | 6900 |
|
|
2013
Q2 | – | Hold |
0
| – | – | – | 6687 |
|
Other funds holding PSTV
VCM
VFT
TSS
XT
Barclays's PSTV Position: Q1 2026 in Review
Barclays held its Plus Therapeutics (PSTV) position steady in Q1 2026 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #5347.
Barclays first reported a position in PSTV in Q3 2018 and has held it in 4 quarters since. The position peaked at $29K in Q4 2018. 23 funds tracked by Wall St. Rank hold PSTV as of Q1 2026.
- Barclays held 0 shares of Plus Therapeutics worth $0 as of Q1 2026.
- Barclays left its Plus Therapeutics share count unchanged in Q1 2026.
- Plus Therapeutics made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #5347 holding.
- Barclays first reported a position in Plus Therapeutics in Q3 2018 and has held it in 4 quarters since.
- Barclays's Plus Therapeutics position peaked at $29K in Q4 2018.
- 23 funds tracked by Wall St. Rank held Plus Therapeutics as of Q1 2026.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.